Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Dusser

Showing results (21-30 of 62) with videos related to

Pageof 7
Sort By:
International Journal of Chronic Obstructive Pulmonary Disease|February 9, 2016
Differences in outcomes between GOLD groups in patients with COPD in the TIOSPIR(®) trialDaniel Dusser, Robert A Wise, Ronald Dahl, et al.
American Journal of Respiratory and Critical Care Medicine|October 27, 2004
One-year outcome after severe pulmonary exacerbation in adults with cystic fibrosisMadiha Ellaffi, Christophe Vinsonneau, Joël Coste, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|October 7, 2004
Diagnosis of cystic fibrosis in adults with diffuse bronchiectasisDominique Hubert, Isabelle Fajac, Thierry Bienvenu, et al.
International Journal of Chronic Obstructive Pulmonary Disease|December 15, 2017
Determinants of exacerbation risk in patients with COPD in the TIOSPIR studyPeter Ma Calverley, Kay Tetzlaff, Daniel Dusser, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|October 7, 2004
Diagnosis of cystic fibrosis in adults with diffuse bronchiectasisDominique Hubert, Isabelle Fajac, Thierry Bienvenu, et al.
BMJ Open|December 31, 2015
Safety and efficacy of tiotropium in patients switching from HandiHaler to Respimat in the TIOSPIR trialRonald Dahl, Peter M A Calverley, Antonio Anzueto, et al.
NPJ Primary Care Respiratory Medicine|November 6, 2015
Safety and efficacy of tiotropium Respimat versus HandiHaler in patients naive to treatment with inhaled anticholinergics: a post hoc analysis of the TIOSPIR trialRobert Wise, Peter M A Calverley, Ronald Dahl, et al.
American Journal of Respiratory and Critical Care Medicine|February 20, 2010
Cystic fibrosis transmembrane conductance regulator channel dysfunction in non-cystic fibrosis bronchiectasisThierry Bienvenu, Isabelle Sermet-Gaudelus, Pierre-Regis Burgel, et al.
Journal of Aerosol Medicine and Pulmonary Drug Delivery|February 10, 2016
Pharmacodynamics and Pharmacokinetics Following Once-Daily and Twice-Daily Dosing of Tiotropium Respimat<sup>®</sup> in Asthma Using Standardized Sample-Contamination AvoidanceKai-Michael Beeh, Anne-Marie Kirsten, Daniel Dusser, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|September 29, 2015
Renin-associated hypertension after bronchial artery embolization in cystic fibrosisNathalie Coolen, Hervé Gouya, Reem Kanaan, et al.
Pageof 7

Showing results (21-30 of 62) with videos related to

Sort By:
Pageof 7
International Journal of Chronic Obstructive Pulmonary Disease|February 9, 2016
Differences in outcomes between GOLD groups in patients with COPD in the TIOSPIR(®) trialDaniel Dusser, Robert A Wise, Ronald Dahl, et al.
American Journal of Respiratory and Critical Care Medicine|October 27, 2004
One-year outcome after severe pulmonary exacerbation in adults with cystic fibrosisMadiha Ellaffi, Christophe Vinsonneau, Joël Coste, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|October 7, 2004
Diagnosis of cystic fibrosis in adults with diffuse bronchiectasisDominique Hubert, Isabelle Fajac, Thierry Bienvenu, et al.
International Journal of Chronic Obstructive Pulmonary Disease|December 15, 2017
Determinants of exacerbation risk in patients with COPD in the TIOSPIR studyPeter Ma Calverley, Kay Tetzlaff, Daniel Dusser, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|October 7, 2004
Diagnosis of cystic fibrosis in adults with diffuse bronchiectasisDominique Hubert, Isabelle Fajac, Thierry Bienvenu, et al.
BMJ Open|December 31, 2015
Safety and efficacy of tiotropium in patients switching from HandiHaler to Respimat in the TIOSPIR trialRonald Dahl, Peter M A Calverley, Antonio Anzueto, et al.
NPJ Primary Care Respiratory Medicine|November 6, 2015
Safety and efficacy of tiotropium Respimat versus HandiHaler in patients naive to treatment with inhaled anticholinergics: a post hoc analysis of the TIOSPIR trialRobert Wise, Peter M A Calverley, Ronald Dahl, et al.
American Journal of Respiratory and Critical Care Medicine|February 20, 2010
Cystic fibrosis transmembrane conductance regulator channel dysfunction in non-cystic fibrosis bronchiectasisThierry Bienvenu, Isabelle Sermet-Gaudelus, Pierre-Regis Burgel, et al.
Journal of Aerosol Medicine and Pulmonary Drug Delivery|February 10, 2016
Pharmacodynamics and Pharmacokinetics Following Once-Daily and Twice-Daily Dosing of Tiotropium Respimat<sup>®</sup> in Asthma Using Standardized Sample-Contamination AvoidanceKai-Michael Beeh, Anne-Marie Kirsten, Daniel Dusser, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|September 29, 2015
Renin-associated hypertension after bronchial artery embolization in cystic fibrosisNathalie Coolen, Hervé Gouya, Reem Kanaan, et al.
Pageof 7